ÿþ<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:p="urn:schemas-microsoft-com:office:powerpoint" xmlns:a="urn:schemas-microsoft-com:office:access" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:s="uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs="urn:schemas-microsoft-com:rowset" xmlns:z="#RowsetSchema" xmlns:b="urn:schemas-microsoft-com:office:publisher" xmlns:ss="urn:schemas-microsoft-com:office:spreadsheet" xmlns:c="urn:schemas-microsoft-com:office:component:spreadsheet" xmlns:odc="urn:schemas-microsoft-com:office:odc" xmlns:oa="urn:schemas-microsoft-com:office:activation" xmlns:html="http://www.w3.org/TR/REC-html40" xmlns:q="http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc="http://microsoft.com/officenet/conferencing" xmlns:D="DAV:" xmlns:Repl="http://schemas.microsoft.com/repl/" xmlns:mt="http://schemas.microsoft.com/sharepoint/soap/meetings/" xmlns:x2="http://schemas.microsoft.com/office/excel/2003/xml" xmlns:ppda="http://www.passport.com/NameSpace.xsd" xmlns:ois="http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns:dir="http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds="http://www.w3.org/2000/09/xmldsig#" xmlns:dsp="http://schemas.microsoft.com/sharepoint/dsp" xmlns:udc="http://schemas.microsoft.com/data/udc" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:sub="http://schemas.microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec="http://www.w3.org/2001/04/xmlenc#" xmlns:sp="http://schemas.microsoft.com/sharepoint/" xmlns:sps="http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:udcs="http://schemas.microsoft.com/data/udc/soap" xmlns:udcxf="http://schemas.microsoft.com/data/udc/xmlfile" xmlns:udcp2p="http://schemas.microsoft.com/data/udc/parttopart" xmlns:wf="http://schemas.microsoft.com/sharepoint/soap/workflow/" xmlns:dsss="http://schemas.microsoft.com/office/2006/digsig-setup" xmlns:dssi="http://schemas.microsoft.com/office/2006/digsig" xmlns:mdssi="http://schemas.openxmlformats.org/package/2006/digital-signature" xmlns:mver="http://schemas.openxmlformats.org/markup-compatibility/2006" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:mrels="http://schemas.openxmlformats.org/package/2006/relationships" xmlns:spwp="http://microsoft.com/sharepoint/webpartpages" xmlns:ex12t="http://schemas.microsoft.com/exchange/services/2006/types" xmlns:ex12m="http://schemas.microsoft.com/exchange/services/2006/messages" xmlns:pptsl="http://schemas.microsoft.com/sharepoint/soap/SlideLibrary/" xmlns:spsl="http://microsoft.com/webservices/SharePointPortalServer/PublishedLinksService" xmlns:Z="urn:schemas-microsoft-com:" xmlns:st="&#1;" xmlns="http://www.w3.org/TR/REC-html40"> <head> <meta http-equiv=Content-Type content="text/html; charset=unicode"> <meta name=ProgId content=Word.Document> <meta name=Generator content="Microsoft Word 12"> <meta name=Originator content="Microsoft Word 12"> <link rel=File-List href="Lymphoid.files/filelist.xml"> <link rel=Edit-Time-Data href="Lymphoid.files/editdata.mso"> <!--[if !mso]> <style> v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style> <![endif]--> <link rel=themeData href="Lymphoid.files/themedata.thmx"> <link rel=colorSchemeMapping href="Lymphoid.files/colorschememapping.xml"> <!--[if gte mso 9]><xml> <w:WordDocument> <w:TrackMoves/> <w:TrackFormatting/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>RU</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:DoNotExpandShiftReturn/> <w:BreakWrappedTables/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" Priority="39" Name="toc 1"/> <w:LsdException Locked="false" Priority="39" Name="toc 2"/> <w:LsdException Locked="false" Priority="39" Name="toc 3"/> <w:LsdException Locked="false" Priority="39" Name="toc 4"/> <w:LsdException Locked="false" Priority="39" Name="toc 5"/> <w:LsdException Locked="false" Priority="39" Name="toc 6"/> <w:LsdException Locked="false" Priority="39" Name="toc 7"/> <w:LsdException Locked="false" Priority="39" Name="toc 8"/> <w:LsdException Locked="false" Priority="39" Name="toc 9"/> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="TOC Heading"/> </w:LatentStyles> </xml><![endif]--> <style> <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:1; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:variable; mso-font-signature:0 0 0 0 0 0;} @font-face {font-family:Cambria; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:204; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1073741899 0 0 415 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:204; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-520092929 1073786111 9 0 415 0;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:204; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-520081665 -1073717157 41 0 66047 0;} @font-face {font-family:Verdana; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:204; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1593833729 1073750107 16 0 415 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} h1 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 1 =0:"; margin-top:24.0pt; margin-right:0cm; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:1; font-size:14.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; font-weight:bold;} h2 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 2 =0:"; margin-top:10.0pt; margin-right:0cm; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:2; font-size:13.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; font-weight:bold;} h3 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 3 =0:"; margin-top:10.0pt; margin-right:0cm; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; line-height:110%; mso-pagination:widow-orphan; mso-outline-level:3; font-size:11.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; font-weight:bold;} h4 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 4 =0:"; margin-top:10.0pt; margin-right:0cm; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:4; font-size:11.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; font-weight:bold; font-style:italic;} h5 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 5 =0:"; margin-top:10.0pt; margin-right:0cm; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:5; font-size:11.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#7F7F7F; font-weight:bold;} h6 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 6 =0:"; margin:0cm; margin-bottom:.0001pt; line-height:110%; mso-pagination:widow-orphan; mso-outline-level:6; font-size:11.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; color:#7F7F7F; font-weight:bold; font-style:italic;} p.MsoHeading7, li.MsoHeading7, div.MsoHeading7 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 7 =0:"; margin:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:7; font-size:11.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; font-style:italic;} p.MsoHeading8, li.MsoHeading8, div.MsoHeading8 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 8 =0:"; margin:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:8; font-size:10.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman";} p.MsoHeading9, li.MsoHeading9, div.MsoHeading9 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"03>;>2>: 9 =0:"; margin:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; mso-outline-level:9; font-size:10.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; letter-spacing:.25pt; font-style:italic;} p.MsoTitle, li.MsoTitle, div.MsoTitle {mso-style-priority:10; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"0720=85 =0:"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; mso-pagination:widow-orphan; font-size:26.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; letter-spacing:.25pt;} p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle {mso-style-priority:11; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:">4703>;>2>: =0:"; margin-top:0cm; margin-right:0cm; margin-bottom:30.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; letter-spacing:.65pt; font-style:italic;} a:link, span.MsoHyperlink {mso-style-noshow:yes; mso-style-priority:99; color:blue; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; mso-style-priority:99; color:purple; text-decoration:underline; text-underline:single;} em {mso-style-priority:20; mso-style-unhide:no; mso-style-qformat:yes; letter-spacing:.5pt; border:none windowtext 1.0pt; mso-border-alt:none windowtext 0cm; padding:0cm; font-weight:bold;} p {mso-style-priority:99; margin-top:0cm; margin-right:0cm; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} p.MsoAcetate, li.MsoAcetate, div.MsoAcetate {mso-style-noshow:yes; mso-style-priority:99; mso-style-link:""5:AB 2K=>A:8 =0:"; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:8.0pt; font-family:"Tahoma","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing {mso-style-priority:1; mso-style-unhide:no; mso-style-qformat:yes; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph {mso-style-priority:34; mso-style-unhide:no; mso-style-qformat:yes; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:36.0pt; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} p.MsoQuote, li.MsoQuote, div.MsoQuote {mso-style-priority:29; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"&8B0B0 2 =0:"; margin-top:10.0pt; margin-right:18.0pt; margin-bottom:0cm; margin-left:18.0pt; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; font-style:italic;} p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote {mso-style-priority:30; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"K45;5==0O F8B0B0 =0:"; margin-top:10.0pt; margin-right:57.6pt; margin-bottom:14.0pt; margin-left:50.4pt; text-align:justify; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; font-weight:bold; font-style:italic;} span.MsoSubtleEmphasis {mso-style-priority:19; mso-style-unhide:no; mso-style-qformat:yes; font-style:italic;} span.MsoIntenseEmphasis {mso-style-priority:21; mso-style-unhide:no; mso-style-qformat:yes; font-weight:bold;} span.MsoSubtleReference {mso-style-priority:31; mso-style-unhide:no; mso-style-qformat:yes; font-variant:small-caps;} span.MsoIntenseReference {mso-style-priority:32; mso-style-unhide:no; mso-style-qformat:yes; font-variant:small-caps; letter-spacing:.25pt; text-decoration:underline; text-underline:single;} span.MsoBookTitle {mso-style-priority:33; mso-style-unhide:no; mso-style-qformat:yes; font-variant:small-caps; letter-spacing:.25pt; font-style:italic;} p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading {mso-style-priority:39; mso-style-unhide:no; mso-style-qformat:yes; margin-top:24.0pt; margin-right:0cm; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; line-height:115%; mso-pagination:widow-orphan; font-size:14.0pt; font-family:"Cambria","serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; font-weight:bold;} span.1 {mso-style-name:"03>;>2>: 1 =0:"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 1"; mso-ansi-font-size:14.0pt; mso-bidi-font-size:14.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#365F91; mso-themecolor:accent1; mso-themeshade:191; font-weight:bold;} span.2 {mso-style-name:"03>;>2>: 2 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 2"; mso-ansi-font-size:13.0pt; mso-bidi-font-size:13.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; mso-themecolor:accent1; font-weight:bold;} span.3 {mso-style-name:"03>;>2>: 3 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 3"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; mso-themecolor:accent1; font-weight:bold;} span.4 {mso-style-name:"03>;>2>: 4 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 4"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; mso-themecolor:accent1; font-weight:bold; font-style:italic;} span.5 {mso-style-name:"03>;>2>: 5 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 5"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#243F60; mso-themecolor:accent1; mso-themeshade:127;} span.6 {mso-style-name:"03>;>2>: 6 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 6"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#243F60; mso-themecolor:accent1; mso-themeshade:127; font-style:italic;} span.7 {mso-style-name:"03>;>2>: 7 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 7"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#404040; mso-themecolor:text1; mso-themetint:191; font-style:italic;} span.8 {mso-style-name:"03>;>2>: 8 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 8"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#404040; mso-themecolor:text1; mso-themetint:191;} span.9 {mso-style-name:"03>;>2>: 9 =0:"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"03>;>2>: 9"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#404040; mso-themecolor:text1; mso-themetint:191; font-style:italic;} span.a {mso-style-name:"0720=85 =0:"; mso-style-priority:10; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:0720=85; mso-ansi-font-size:26.0pt; mso-bidi-font-size:26.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#17365D; mso-themecolor:text2; mso-themeshade:191; letter-spacing:.25pt; mso-font-kerning:14.0pt;} span.a0 {mso-style-name:">4703>;>2>: =0:"; mso-style-priority:11; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:>4703>;>2>:; mso-ansi-font-size:12.0pt; mso-bidi-font-size:12.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; mso-themecolor:accent1; letter-spacing:.75pt; font-style:italic;} span.a1 {mso-style-name:""5:AB 2K=>A:8 =0:"; mso-style-noshow:yes; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:""5:AB 2K=>A:8"; mso-ansi-font-size:8.0pt; mso-bidi-font-size:8.0pt; font-family:"Tahoma","sans-serif"; mso-ascii-font-family:Tahoma; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Tahoma; mso-bidi-font-family:Tahoma;} span.20 {mso-style-name:"&8B0B0 2 =0:"; mso-style-priority:29; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"&8B0B0 2"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-bidi-font-family:Calibri; color:black; mso-themecolor:text1; font-style:italic;} span.a2 {mso-style-name:"K45;5==0O F8B0B0 =0:"; mso-style-priority:30; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"K45;5==0O F8B0B0"; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-bidi-font-family:Calibri; color:#4F81BD; mso-themecolor:accent1; font-weight:bold; font-style:italic;} p.Heading1, li.Heading1, div.Heading1 {mso-style-name:"Heading 1"; mso-style-unhide:no; mso-style-link:"Heading 1 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading1Char {mso-style-name:"Heading 1 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 1"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; font-weight:bold;} p.Heading2, li.Heading2, div.Heading2 {mso-style-name:"Heading 2"; mso-style-unhide:no; mso-style-link:"Heading 2 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading2Char {mso-style-name:"Heading 2 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 2"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; font-weight:bold;} p.Heading3, li.Heading3, div.Heading3 {mso-style-name:"Heading 3"; mso-style-unhide:no; mso-style-link:"Heading 3 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading3Char {mso-style-name:"Heading 3 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 3"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; font-weight:bold;} p.Heading4, li.Heading4, div.Heading4 {mso-style-name:"Heading 4"; mso-style-unhide:no; mso-style-link:"Heading 4 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading4Char {mso-style-name:"Heading 4 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 4"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; font-weight:bold; font-style:italic;} p.Heading5, li.Heading5, div.Heading5 {mso-style-name:"Heading 5"; mso-style-unhide:no; mso-style-link:"Heading 5 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading5Char {mso-style-name:"Heading 5 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 5"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; color:#7F7F7F; font-weight:bold;} p.Heading6, li.Heading6, div.Heading6 {mso-style-name:"Heading 6"; mso-style-unhide:no; mso-style-link:"Heading 6 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading6Char {mso-style-name:"Heading 6 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 6"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; color:#7F7F7F; font-weight:bold; font-style:italic;} p.Heading7, li.Heading7, div.Heading7 {mso-style-name:"Heading 7"; mso-style-unhide:no; mso-style-link:"Heading 7 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading7Char {mso-style-name:"Heading 7 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 7"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; font-style:italic;} p.Heading8, li.Heading8, div.Heading8 {mso-style-name:"Heading 8"; mso-style-unhide:no; mso-style-link:"Heading 8 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading8Char {mso-style-name:"Heading 8 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 8"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria;} p.Heading9, li.Heading9, div.Heading9 {mso-style-name:"Heading 9"; mso-style-unhide:no; mso-style-link:"Heading 9 Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.Heading9Char {mso-style-name:"Heading 9 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 9"; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; letter-spacing:.25pt; font-style:italic;} p.Title, li.Title, div.Title {mso-style-name:Title; mso-style-unhide:no; mso-style-link:"Title Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.TitleChar {mso-style-name:"Title Char"; mso-style-priority:10; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:Title; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; letter-spacing:.25pt;} p.Subtitle, li.Subtitle, div.Subtitle {mso-style-name:Subtitle; mso-style-unhide:no; mso-style-link:"Subtitle Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.SubtitleChar {mso-style-name:"Subtitle Char"; mso-style-priority:11; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:Subtitle; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-hansi-font-family:Cambria; letter-spacing:.65pt; font-style:italic;} p.Quote, li.Quote, div.Quote {mso-style-name:Quote; mso-style-unhide:no; mso-style-link:"Quote Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.QuoteChar {mso-style-name:"Quote Char"; mso-style-priority:29; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:Quote; font-style:italic;} p.IntenseQuote, li.IntenseQuote, div.IntenseQuote {mso-style-name:"Intense Quote"; mso-style-unhide:no; mso-style-link:"Intense Quote Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.IntenseQuoteChar {mso-style-name:"Intense Quote Char"; mso-style-priority:30; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Intense Quote"; font-weight:bold; font-style:italic;} p.BalloonText, li.BalloonText, div.BalloonText {mso-style-name:"Balloon Text"; mso-style-unhide:no; mso-style-link:"Balloon Text Char"; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} span.BalloonTextChar {mso-style-name:"Balloon Text Char"; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Balloon Text"; font-family:"Tahoma","sans-serif"; mso-ascii-font-family:Tahoma; mso-hansi-font-family:Tahoma; mso-bidi-font-family:Tahoma;} span.EmailStyle74 {mso-style-type:personal; mso-style-noshow:yes; mso-style-unhide:no; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-hansi-font-family:Calibri; mso-bidi-font-family:Calibri; color:windowtext;} span.titleheading1 {mso-style-name:titleheading1; mso-style-unhide:no; color:#096BF4; font-weight:bold;} span.titleauthor1 {mso-style-name:titleauthor1; mso-style-unhide:no; font-weight:bold;} span.bluetext1 {mso-style-name:bluetext1; mso-style-unhide:no; color:#096BF4;} span.EmailStyle78 {mso-style-type:personal; mso-style-noshow:yes; mso-style-unhide:no; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-hansi-font-family:Calibri; mso-bidi-font-family:Calibri; color:#1F497D;} span.EmailStyle79 {mso-style-type:personal-reply; mso-style-noshow:yes; mso-style-unhide:no; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; color:#1F497D; mso-themecolor:dark2;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:612.0pt 792.0pt; margin:70.85pt 70.85pt 70.85pt 70.85pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} /* List Definitions */ @list l0 {mso-list-id:887567458; mso-list-template-ids:-929802902;} @list l0:level1 {mso-level-number-format:bullet; mso-level-text:·ð; mso-level-tab-stop:36.0pt; mso-level-number-position:left; text-indent:-18.0pt; mso-ansi-font-size:10.0pt; font-family:Symbol;} @list l1 {mso-list-id:1119372039; mso-list-template-ids:920535830;} @list l1:level1 {mso-level-number-format:bullet; mso-level-text:·ð; mso-level-tab-stop:36.0pt; mso-level-number-position:left; text-indent:-18.0pt; mso-ansi-font-size:10.0pt; font-family:Symbol;} @list l1:level2 {mso-level-tab-stop:72.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level3 {mso-level-tab-stop:108.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level4 {mso-level-tab-stop:144.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level5 {mso-level-tab-stop:180.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level6 {mso-level-tab-stop:216.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level7 {mso-level-tab-stop:252.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level8 {mso-level-tab-stop:288.0pt; mso-level-number-position:left; text-indent:-18.0pt;} @list l1:level9 {mso-level-tab-stop:324.0pt; mso-level-number-position:left; text-indent:-18.0pt;} ol {margin-bottom:0cm;} ul {margin-bottom:0cm;} --> </style> <!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"1KG=0O B01;8F0"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} </style> <![endif]--><!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="1026"/> </xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit"> <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--> </head> <body bgcolor=white lang=RU link=blue vlink=purple style='tab-interval:35.4pt'> <div class=WordSection1> <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><span style='color:black'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><o:p>&nbsp;</o:p></p> <div> <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal'><span style='font-size:12.0pt;font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p> </div> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='mso-cellspacing:0cm;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td valign=top style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal>&nbsp;<o:p></o:p></p> <p class=MsoNormal><span lang=EN-US style='color:black;mso-ansi-language: EN-US'>Hodder Arnold has just published new book in Oncology</span><span lang=EN-US style='mso-ansi-language:EN-US'>:<o:p></o:p></span></p> <table class=MsoNormalTable border=0 cellspacing=10 cellpadding=0 width=663 style='width:397.5pt;mso-cellspacing:6.0pt;mso-yfti-tbllook:1184;mso-padding-alt: 0cm 0cm 0cm 0cm'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'> <td width=206 valign=top style='width:123.75pt;padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f"> <v:stroke joinstyle="miter"/> <v:formulas> <v:f eqn="if lineDrawn pixelLineWidth 0"/> <v:f eqn="sum @0 1 0"/> <v:f eqn="sum 0 0 @1"/> <v:f eqn="prod @2 1 2"/> <v:f eqn="prod @3 21600 pixelWidth"/> <v:f eqn="prod @3 21600 pixelHeight"/> <v:f eqn="sum @0 0 1"/> <v:f eqn="prod @6 1 2"/> <v:f eqn="prod @7 21600 pixelWidth"/> <v:f eqn="sum @8 21600 0"/> <v:f eqn="prod @7 21600 pixelHeight"/> <v:f eqn="sum @10 21600 0"/> </v:formulas> <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/> <o:lock v:ext="edit" aspectratio="t"/> </v:shapetype><v:shape id="title_details1_img_title" o:spid="_x0000_i1025" type="#_x0000_t75" alt="http://217.169.40.204/Websites/Images/Store/books-web/9780340809471-1-1.jpg" style='width:115.8pt;height:150pt'> <v:imagedata src="Lymphoid.files/image001.jpg" o:href="cid:BE81F73F7CBC486BB30F90ADF11DD285@sunny"/> </v:shape><![endif]--><![if !vml]><img width=154 height=200 src="Lymphoid.files/image001.jpg" alt="http://217.169.40.204/Websites/Images/Store/books-web/9780340809471-1-1.jpg" v:shapes="title_details1_img_title"><![endif]><o:p></o:p></span></p> </td> <td width=13 style='width:7.5pt;padding:0cm 0cm 0cm 0cm'></td> <td valign=top style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><span class=titleheading1><span style='font-size:12.0pt;line-height:115%;font-family:"Verdana","sans-serif"'>The Lymphoid Neoplasms 3ed</span></span><span style='font-size:10.0pt; line-height:115%;font-family:"Verdana","sans-serif";color:#565656'> <br> </span><span class=titleauthor1><span style='font-size:12.0pt;line-height: 115%;font-family:"Verdana","sans-serif";color:#565656'>Edited by Ian Magrath</span></span><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span style='font-size:10.0pt;line-height:115%;font-family:"Verdana","sans-serif"; color:#565656'>Hardback<o:p></o:p></span></p> <p class=MsoNormal><span class=bluetext1><b><span style='font-size:10.0pt; line-height:115%;font-family:"Verdana","sans-serif"'>£185.00</span></b></span><span style='font-size:10.0pt;line-height:115%;font-family:"Verdana","sans-serif"; color:#565656'> <br> <br> <b>ISBN: </b>9780340809471 <o:p></o:p></span></p> <p class=MsoNormal><b><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'>Published:</span></b><span style='font-size:10.0pt;line-height:115%;font-family:"Verdana","sans-serif"; color:#565656'> 30/07/2010 <o:p></o:p></span></p> <p class=MsoNormal><b><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'>Extent: </span></b><span style='font-size:10.0pt;line-height:115%;font-family:"Verdana","sans-serif"; color:#565656'>1344 pages <o:p></o:p></span></p> <p class=MsoNormal><b><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'>Illustrations: </span></b><span style='font-size:10.0pt;line-height:115%;font-family:"Verdana","sans-serif"; color:#565656'>180 B&amp;W line, 150 B&amp;W HT, 50 colour HT <o:p></o:p></span></p> </td> </tr> </table> </td> </tr> <tr style='mso-yfti-irow:1;height:1.5pt'> <td style='padding:0cm 0cm 0cm 0cm;height:1.5pt' id=paleRoundedBotttom></td> </tr> <tr style='mso-yfti-irow:2'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%;font-family: "Verdana","sans-serif";color:#565656'><!--[if gte vml 1]><v:shape id="Picture_x0020_4" o:spid="_x0000_i1026" type="#_x0000_t75" alt="*" style='width:397.2pt; height:6.6pt'> <v:imagedata src="Lymphoid.files/image002.gif" o:href="cid:84CDDE67A4304C1396A6AC5703FA03C4@sunny"/> </v:shape><![endif]--><![if !vml]><img width=530 height=9 src="Lymphoid.files/image002.gif" alt="*" v:shapes="Picture_x0020_4"><![endif]><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes'> <td style='padding:0cm 0cm 0cm 0cm'> <table class=MsoNormalTable border=0 cellspacing=10 cellpadding=0 width=663 style='width:397.5pt;mso-cellspacing:6.0pt;mso-yfti-tbllook:1184;mso-padding-alt: 0cm 0cm 0cm 0cm' id=whiteRoundedMainBG> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'> <td valign=top style='padding:0cm 0cm 0cm 0cm'> <p><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:#565656'>Summary:</span></b><span style='font-size:10.0pt;font-family: "Verdana","sans-serif";color:#565656'> <br> This comprehensive and authoritative reference covers all aspects of the group of disorders collectively known as the lymphoid neoplasms. The reader is taken through a description of its normal cellular origins and the molecular genetic abnormalities that can lead to this group of conditions, a section of the book that has been considerably strengthened for this third edition, to the environmental factors that may be relevant to disease development, and, finally, to the pragmatic aspects of disease management.&nbsp;The authors synthesise for the reader apsects of current knowledge and likely future developments, and direct them to the appropriate resources should they wish to pursue particular avenues of scientific or literature research. <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><o:p>&nbsp;</o:p></span></p> <ul type=disc> <li class=MsoNormal style='color:#565656;mso-margin-top-alt:auto; mso-margin-bottom-alt:auto;line-height:normal;mso-list:l1 level1 lfo3; tab-stops:list 36.0pt'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman"'>Now includes Hodgkin's Disease and the acute lymphoblastic leukemias  a  one-stop-shop</span><span style='mso-fareast-font-family:"Times New Roman"'> </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman"'><o:p></o:p></span></li> <li class=MsoNormal style='color:#565656;mso-margin-top-alt:auto; mso-margin-bottom-alt:auto;line-height:normal;mso-list:l1 level1 lfo3; tab-stops:list 36.0pt'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman"'>Improved consistency of style, structure and approach between chapters</span><span style='mso-fareast-font-family:"Times New Roman"'> </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman"'><o:p></o:p></span></li> <li class=MsoNormal style='color:#565656;mso-margin-top-alt:auto; mso-margin-bottom-alt:auto;line-height:normal;mso-list:l1 level1 lfo3; tab-stops:list 36.0pt'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman"'>New text features  summary points, text boxes, reference annotation</span><span style='mso-fareast-font-family: "Times New Roman"'> </span><span style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li> <li class=MsoNormal style='color:#565656;mso-margin-top-alt:auto; mso-margin-bottom-alt:auto;line-height:normal;mso-list:l1 level1 lfo3; tab-stops:list 36.0pt'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman"'>Improved coverage of the basic science aspects</span><span style='mso-fareast-font-family:"Times New Roman"'> </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li> </ul> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><o:p>&nbsp;</o:p></span></p> <p style='margin-bottom:12.0pt'><b><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";color:#565656'>Table of Contents:</span></b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#565656'> <br> <!--[if gte vml 1]><v:shape id="Picture_x0020_5" o:spid="_x0000_i1027" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_5"><![endif]>Part I: INTRODUCTION<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_6" o:spid="_x0000_i1028" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_6"><![endif]>1. Conceptual basis<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_7" o:spid="_x0000_i1029" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_7"><![endif]>2. History<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_8" o:spid="_x0000_i1030" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_8"><![endif]>Part II: EPIDEMIOLOGY<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_9" o:spid="_x0000_i1031" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_9"><![endif]>3. Descriptive epidemiology<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_10" o:spid="_x0000_i1032" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_10"><![endif]>4. Causes and prevention of lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_11" o:spid="_x0000_i1033" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_11"><![endif]>5. Immunological and genetic predisposition<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_12" o:spid="_x0000_i1034" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_12"><![endif]>6. Retroviruses<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_13" o:spid="_x0000_i1035" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_13"><![endif]>7. Herpesviruses<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_14" o:spid="_x0000_i1036" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_14"><![endif]>8. Other microorganisms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_15" o:spid="_x0000_i1037" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_15"><![endif]>Part III: IMMUNOBIOLOGY<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_16" o:spid="_x0000_i1038" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_16"><![endif]>9. Overview of the immune system<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_17" o:spid="_x0000_i1039" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_17"><![endif]>10. Ontogeny of T and NK cells<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_18" o:spid="_x0000_i1040" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_18"><![endif]>11. Ontogeny of B cells<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_19" o:spid="_x0000_i1041" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_19"><![endif]>12. Cellular immunobiology of lymph nodes and spleen<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_20" o:spid="_x0000_i1042" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_20"><![endif]>13. Cellular immunobiology of extranodal lymphoid tissue<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_21" o:spid="_x0000_i1043" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_21"><![endif]>14. Terminal B cell differentiation<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_22" o:spid="_x0000_i1044" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_22"><![endif]>15. Interleukins and the cytological composition of lymphoid neoplasms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_23" o:spid="_x0000_i1045" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_23"><![endif]>16. Lymphocyte homing: relevance to clinical syndromes<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_24" o:spid="_x0000_i1046" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_24"><![endif]>17. Pathobiology of apoptosis in lymphocytes<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_25" o:spid="_x0000_i1047" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_25"><![endif]>18. Somatic hypermutation mechanism in the pathogenesis of lymphoid neoplasms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_26" o:spid="_x0000_i1048" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_26"><![endif]>19. Animal models of human lymphoid neoplasms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_27" o:spid="_x0000_i1049" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_27"><![endif]>Part IV: CLASSIFICATION AND PATHOGENESIS<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_28" o:spid="_x0000_i1050" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_28"><![endif]>20. Pathological anatomy of the immune system<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_29" o:spid="_x0000_i1051" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_29"><![endif]>21. The classification of lymphoid neoplasia<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_30" o:spid="_x0000_i1052" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_30"><![endif]>22. Borderland between pathological entities: composite lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_31" o:spid="_x0000_i1053" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_31"><![endif]>23. Cytogenetics of lymphoid neoplasia<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_32" o:spid="_x0000_i1054" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_32"><![endif]>24. Molecular basis of chromosomal translocations<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_33" o:spid="_x0000_i1055" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_33"><![endif]>25. Molecular genetics of lymphoid neoplasia<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_34" o:spid="_x0000_i1056" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_34"><![endif]>26. Gene expression patterns in lymphoma classification<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_35" o:spid="_x0000_i1057" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_35"><![endif]>27. Immunodeficieny, inherited and acquired, and lymphomagenesis<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_36" o:spid="_x0000_i1058" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_36"><![endif]>28. Chronic inflammation, including autoimmunity, and lymphogenesis<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_37" o:spid="_x0000_i1059" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_37"><![endif]>Part V: PATHOLOGY AND PATHOGENESIS OF SPECIFIC LYMPHOMAS<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_38" o:spid="_x0000_i1060" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_38"><![endif]>29. Lymphoblastic lymphomas and leukemias<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_39" o:spid="_x0000_i1061" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_39"><![endif]>30. Small cell leukemias and lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_40" o:spid="_x0000_i1062" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_40"><![endif]>31. Hairy cell leukemia<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_41" o:spid="_x0000_i1063" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_41"><![endif]>32. Mantle cell lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_42" o:spid="_x0000_i1064" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_42"><![endif]>33. Marginal zone lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_43" o:spid="_x0000_i1065" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_43"><![endif]>34. Follicular lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_44" o:spid="_x0000_i1066" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_44"><![endif]>35. Burkitt's lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_45" o:spid="_x0000_i1067" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_45"><![endif]>36. Diffuse large B-cell lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_46" o:spid="_x0000_i1068" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_46"><![endif]>37. Hodgkin's lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_47" o:spid="_x0000_i1069" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_47"><![endif]>38. Plasma cell neoplasms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_48" o:spid="_x0000_i1070" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_48"><![endif]>39. NK cell lymphomas and leukemias<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_49" o:spid="_x0000_i1071" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_49"><![endif]>40. Anaplastic large cell lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_50" o:spid="_x0000_i1072" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_50"><![endif]>41. Mycosis fungoides and Sezary Syndrome<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_51" o:spid="_x0000_i1073" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_51"><![endif]>42. Other peripheral T cell lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_52" o:spid="_x0000_i1074" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_52"><![endif]>Part VI: PRESENTING FEATURES, DIAGNOSIS, STAGING<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_53" o:spid="_x0000_i1075" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_53"><![endif]>43. Presenting features of lymphoid neoplasms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_54" o:spid="_x0000_i1076" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_54"><![endif]>44. Histological diagnosis<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_55" o:spid="_x0000_i1077" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_55"><![endif]>45. Immunophenotyping as a diagnostic tool<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_56" o:spid="_x0000_i1078" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_56"><![endif]>46. Genetic studies in determining diagnosis and assessing prognosis<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_57" o:spid="_x0000_i1079" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_57"><![endif]>47. Radiological, ultrasound and nuclear magnetic resonance imaging<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_58" o:spid="_x0000_i1080" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_58"><![endif]>48. Radionuclide imaging<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_59" o:spid="_x0000_i1081" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_59"><![endif]>49. Staging systems and staging investigations<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_60" o:spid="_x0000_i1082" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_60"><![endif]>50. Special aspects of diagnosis in developing countries<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_61" o:spid="_x0000_i1083" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_61"><![endif]>51. Imaging in Developing Countries<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_62" o:spid="_x0000_i1084" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_62"><![endif]>Part VII: GENERAL PRINCIPLES OF MANAGEMENT<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_63" o:spid="_x0000_i1085" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_63"><![endif]>52. Emergency management<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_64" o:spid="_x0000_i1086" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_64"><![endif]>53. Systemic therapy<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_65" o:spid="_x0000_i1087" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_65"><![endif]>54. Radiation therapy<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_66" o:spid="_x0000_i1088" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_66"><![endif]>55. Surgery in diagnosis and treatment<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_67" o:spid="_x0000_i1089" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_67"><![endif]>56. Assessment of response and follow up<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_68" o:spid="_x0000_i1090" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_68"><![endif]>57. Supportive care in lymphoid neoplasia<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_69" o:spid="_x0000_i1091" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_69"><![endif]>58. Prognostic factors and risk adaptation<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_70" o:spid="_x0000_i1092" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_70"><![endif]>59. Second line therapy<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_71" o:spid="_x0000_i1093" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_71"><![endif]>60. High dose therapy with stem cell rescue<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_72" o:spid="_x0000_i1094" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_72"><![endif]>61. Management of lymphoid neoplasms during pregnancy<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_73" o:spid="_x0000_i1095" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_73"><![endif]>62. Management of lymphoid neoplasms in the infant<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_74" o:spid="_x0000_i1096" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_74"><![endif]>63. Management of lymphoid neoplasms in the elderly<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_75" o:spid="_x0000_i1097" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_75"><![endif]>64. Management of lymphomas at extranodal locations<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_76" o:spid="_x0000_i1098" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_76"><![endif]>65. Management of lymphomas in developing countries<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_77" o:spid="_x0000_i1099" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_77"><![endif]>66. Late effects of treatment/quality of life<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_78" o:spid="_x0000_i1100" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_78"><![endif]>Part VIII: MANAGEMENT OF SPECIFIC DISEASES<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_79" o:spid="_x0000_i1101" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_79"><![endif]>67. Lymphoblastic lymphoma and leukemia in children<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_80" o:spid="_x0000_i1102" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_80"><![endif]>68. Lymphoblastic lympomas and leukemias in adults<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_81" o:spid="_x0000_i1103" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_81"><![endif]>69. Small B cell lymphomas and leukemias with hairy cell lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_82" o:spid="_x0000_i1104" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_82"><![endif]>70. Mantle cell lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_83" o:spid="_x0000_i1105" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_83"><![endif]>71. Marginal zone, including MALT associated lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_84" o:spid="_x0000_i1106" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_84"><![endif]>72. Follicular lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_85" o:spid="_x0000_i1107" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_85"><![endif]>73. Burkitt and Burkitt like lymphomas/leukemia in children<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_86" o:spid="_x0000_i1108" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_86"><![endif]>74. Burkitt and Burkitt like lymphoma/leukemia in adults<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_87" o:spid="_x0000_i1109" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_87"><![endif]>75. Diffuse large B cell lymphoma in children<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_88" o:spid="_x0000_i1110" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_88"><![endif]>76. Diffuse large B cell lymphomas in adults<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_89" o:spid="_x0000_i1111" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_89"><![endif]>77. Hodgkin's lymphoma in adults<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_90" o:spid="_x0000_i1112" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_90"><![endif]>78. Hodgkin's lymphoma in children<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_91" o:spid="_x0000_i1113" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_91"><![endif]>79. Plasma cell neoplasms<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_92" o:spid="_x0000_i1114" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_92"><![endif]>80. Leukemias and lymphomas of NK cell origin<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_93" o:spid="_x0000_i1115" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_93"><![endif]>81. Anaplastic large cell lymphoma in adults<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_94" o:spid="_x0000_i1116" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_94"><![endif]>82. Anaplastic large cell lymphoma in children<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_95" o:spid="_x0000_i1117" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_95"><![endif]>83. Mycosis fungoides and Sezary Syndrome<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_96" o:spid="_x0000_i1118" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_96"><![endif]>84. Adult T-cell leukemia/lymphoma<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_97" o:spid="_x0000_i1119" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_97"><![endif]>85. Peripheral T cell lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_98" o:spid="_x0000_i1120" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_98"><![endif]>86. HIV-associated lymphomas<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_99" o:spid="_x0000_i1121" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_99"><![endif]>87. Lymphoid neoplasms in individuals with underlying chronic diseases<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_100" o:spid="_x0000_i1122" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_100"><![endif]>88. Unusual lymphoid neoplasms in children<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_101" o:spid="_x0000_i1123" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_101"><![endif]>Part IX: FUTURE DIRECTIONS IN DIAGNOSIS AND TREATMENT<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_102" o:spid="_x0000_i1124" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_102"><![endif]>89. Applications of genomic and epigenetic studies<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_103" o:spid="_x0000_i1125" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_103"><![endif]>90. New drugs<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_104" o:spid="_x0000_i1126" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_104"><![endif]>91. Monoclonal antibody therapy<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_105" o:spid="_x0000_i1127" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_105"><![endif]>92. Cellular therapies<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_106" o:spid="_x0000_i1128" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_106"><![endif]>93. Vaccine therapies<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_107" o:spid="_x0000_i1129" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_107"><![endif]>94. Normal Cellular Infiltrates in Diagnosis, Prognosis and Management<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_108" o:spid="_x0000_i1130" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_108"><![endif]>95. Molecular therapy<br> <!--[if gte vml 1]><v:shape id="Picture_x0020_109" o:spid="_x0000_i1131" type="#_x0000_t75" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" style='width:7.8pt;height:7.8pt'> <v:imagedata src="Lymphoid.files/image003.gif" o:href="cid:304FA15EF6BB4CD6A04293418C0C5425@sunny"/> </v:shape><![endif]--><![if !vml]><img width=10 height=10 src="Lymphoid.files/image003.gif" alt="http://www.hoddereducation.co.uk/HEImages/spacer.gif" v:shapes="Picture_x0020_109"><![endif]>96. Viral Targeted Therapies<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><o:p>&nbsp;</o:p></span></p> <p><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:#565656'>About the Author(s):</span></b><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";color:#565656'> <br> Ian Magrath, International Network for Cancer Treatment &amp; Research, Belgium<br> Paolo Boffetta, International Agency for Research on Cancer, Lyon, France<br> Michael Potter, NIH, Bethesda, USA<br> Harald Stein, University of Berlin, Germany<br> Randy Gascoyne, British Columbia Cancer Agency, Canada<br> Claire Dearden, Royal Marsden Hospital, Sutton, Surrey, UK<br> Volker Diehl, University of Köln, Germany<br> Ama Rohatiner, St Bartholomew's Hospital, London, UK<br> Kishor Bhatia, NIH, Bethesda, USA <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><o:p>&nbsp;</o:p></span></p> <p><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:#565656'>Contributors:</span></b><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";color:#565656'> <br> 14% UK 41% Europe 36% USA 9% ROW <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;line-height:115%; font-family:"Verdana","sans-serif";color:#565656'><o:p>&nbsp;</o:p></span></p> <p><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:#565656'>Readership:</span></b><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";color:#565656'> <br> Medical, Clinical and Radiation Oncologists, Haemato-oncologists, Both trainees and qualified practitioners <o:p></o:p></span></p> </td> </tr> </table> </td> </tr> </table> <p class=MsoNormal><span lang=EN-US style='mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> </div> </body> </html>